ADMA Biologics Set to Present at Annual Healthcare Conference
ADMA Biologics, Inc. (Nasdaq: ADMA), an innovative biopharmaceutical company dedicated to the forefront of specialty biologics, is gearing up for a significant presentation at a prestigious healthcare conference. The firm's management announced that it will participate in the 43rd Annual J.P. Morgan Healthcare Conference taking place in San Francisco. The event, renowned for its focus on healthcare innovation, is scheduled for mid-January, where industry leaders gather to share insights and advancements.
Presentation Details
During this event, ADMA’s presentation is set for the morning of January 13, a date that aligns with the start of the conference. The timing, slated for 10:30 a.m. PT, positions ADMA to engage with an audience eager to learn about new developments in the biopharmaceutical sector, specifically regarding therapies aimed at immunodeficient patients.
Live Audio Webcast Available
For those unable to attend in person, a live audio webcast will be accessible through the investor section of the Company’s website. This allows interested parties to follow the presentation in real-time. Additionally, an archived version of the presentation will be made available shortly after the session concludes, ensuring that anyone who missed it can catch up on what was discussed.
About ADMA Biologics
ADMA Biologics is at the forefront of developing and marketing specialty biologics, focusing especially on treatments designed for patients with weakened immune systems. Their work is critical in the production of biopharmaceuticals that help these individuals not only protect against infections but also manage their conditions more effectively.
Product Portfolio
The company proudly manufactures several U.S. Food and Drug Administration (FDA)-approved plasma-derived biologics, which include BIVIGAM, ASCENIV, and NABI-HB. Each product plays a vital role in addressing the needs of those suffering from primary immunodeficiency and related complications. BIVIGAM serves as an immune globulin therapy essential for treating primary humoral immunodeficiency, while ASCENIV provides a more user-friendly formulation. NABI-HB, also essential, acts against the hepatitis B virus, offering enhanced immunity for patients who are at risk.
Operational Excellence in Boca Raton
ADMA’s manufacturing processes are rooted in a stringent quality assurance framework. Located in Boca Raton, Florida, their FDA-licensed facility is equipped to handle the complex processes necessary for transforming blood plasma into life-saving therapies. The company also engages in sourcing plasma through its ADMA BioCenters subsidiary, underscoring its commitment to maintaining a superior supply chain.
Company’s Vision and Impact
With a mission to address the specific healthcare needs of niche patient populations, ADMA aims to bring innovative solutions to the market. The company's focus extends beyond just treating diseases; they strive to improve the quality of life for individuals facing serious health challenges due to immune deficiencies.
Investor Relations Information
For investor inquiries or more details about the upcoming presentation and ADMA's activities, interested parties can reach out to Argot Partners. They provide further updates and information regarding the company’s operational strategies and future opportunities.
Frequently Asked Questions
What is the focus of ADMA Biologics?
ADMA Biologics specializes in manufacturing and marketing specialty biologics for immunodeficient patients and those at risk for infectious diseases.
When will ADMA's presentation take place?
ADMA will present on January 13, during the J.P. Morgan Healthcare Conference, at 10:30 a.m. PT.
How can I access the presentation?
A live audio webcast of the presentation will be available on the Company's website, with an archived version accessible afterwards.
What products does ADMA manufacture?
ADMA manufactures several FDA-approved biologics, including BIVIGAM, ASCENIV, and NABI-HB, targeting immune deficiencies and infectious disease prevention.
Where is ADMA Biologics' manufacturing facility located?
The company's manufacturing facility is situated in Boca Raton, Florida, ensuring high-quality production standards.
